AlphaStar Capital Management’s Exact Sciences EXAS Stock Holding History

AlphaStar Capital Management’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-5,765	Closed	-$227K	–	323
2022 Q2	$227K	Sell	5,765 -75	-1%	-$4.01K	0.02%	308
2022 Q1	$408K	Hold	5,840	–	–	0.03%	269
2021 Q4	$458K	Sell	5,840 -206	-3%	-$18.2K	0.04%	265
2021 Q3	$582K	Buy	6,046 +685	+13%	+$72.3K	0.04%	248
2021 Q2	$666K	Hold	5,361	–	–	0.09%	167
2021 Q1	$706K	Buy	5,361 +3,516	+191%	+$481K	0.11%	131
2020 Q4	$269K	Buy	+1,845	New	+$223K	0.05%	186
2019 Q3	–	Sell	-1,845	Closed	-$218K	–	219
2019 Q2	$218K	Buy	+1,845	New	+$186K	0.06%	206
2017 Q4	–	Sell	-6,842	Closed	-$322K	–	198
2017 Q3	$322K	Buy	+6,842	New	+$275K	0.32%	59

Other funds holding EXAS

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

AlphaStar Capital Management's EXAS Position: Q3 2022 in Review

AlphaStar Capital Management sold out of Exact Sciences (EXAS) in Q3 2022, closing a stake of 5,765 shares — an estimated $227K sold.

AlphaStar Capital Management first reported a position in EXAS in Q3 2017 and held it in 9 quarters. The position peaked at $706K in Q1 2021. 479 funds tracked by Wall St. Rank hold EXAS as of Q3 2022.

AlphaStar Capital Management reported no remaining Exact Sciences position as of Q3 2022 after selling out during the quarter.
AlphaStar Capital Management sold 5,765 Exact Sciences shares in Q3 2022, an estimated $227K.
AlphaStar Capital Management first reported a position in Exact Sciences in Q3 2017 and held it in 9 quarters.
AlphaStar Capital Management's Exact Sciences position peaked at $706K in Q1 2021.
479 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2022.

Based on AlphaStar Capital Management's 13F filing for Q3 2022, filed 21 Oct 2022.